The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CheckMate 436: A phase 1-2 study to evaluate safety and efficacy of nivolumab plus brentuximab vedotin in patients with CD30-expressing relapsed/refractory non-Hodgkin lymphomas.
 
Paul M. Barr
Consulting or Advisory Role - Abbvie; Celgene; Genentech; Infinity Pharmaceuticals; Novartis; Pharmacyclics; Seagen
Research Funding - Pharmacyclics (Inst)
 
Kenneth Robert Carson
Employment - Flatiron Health
Consulting or Advisory Role - Seagen
Research Funding - Bristol-Myers Squibb; Celgene; Kyowa Hakko Kirin; Seagen
 
Joshua Brody
Honoraria - Gilead Sciences; Janssen; Pharmacyclics; Seagen
Consulting or Advisory Role - Celldex; Merck; Seagen
Speakers' Bureau - Gilead Sciences; Janssen; Pharmacyclics; Seagen
Research Funding - Acerta Pharma; Celgene; Celldex; Gilead Sciences; Merck
Travel, Accommodations, Expenses - Gilead Sciences; Janssen; Pharmacyclics; Seagen
 
Andrei R. Shustov
No Relationships to Disclose
 
Alison J. Moskowitz
Consulting or Advisory Role - Merck; Seagen
Research Funding - Seagen
 
Justin Paul Kline
Consulting or Advisory Role - Merck
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck
 
Kerry J. Savage
Honoraria - Bristol-Myers Squibb; Gilead Sciences; Infinity Pharmaceuticals; Merck; Seagen
Consulting or Advisory Role - Bristol-Myers Squibb; Gilead Sciences; Infinity Pharmaceuticals; Merck; Seagen
Speakers' Bureau - Seagen
 
John Kuruvilla
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Gilead Sciences; Janssen; Lundbeck; Merck; Roche; Seagen
Consulting or Advisory Role - Bristol-Myers Squibb; Gilead Sciences; Janssen; Roche; Seagen
Research Funding - Celgene; Karyopharm Therapeutics; Roche
 
Mary S. Campbell
Employment - Seagen
Stock and Other Ownership Interests - CTI; Seagen
 
Pier Luigi Zinzani
Honoraria - Celgene; Gilead Sciences; Janssen
Consulting or Advisory Role - Janssen; Roche; Takeda
Speakers' Bureau - Janssen; Roche; SERVIER
 
Gilles A. Salles
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Gilead Sciences; Gilead Sciences; Janssen; Mundipharma; Roche/Genentech; SERVIER
Consulting or Advisory Role - Celgene; Gilead Sciences; Janssen; Novartis; NOvimmune; Roche/Genentech
Research Funding - Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Roche/Genentech
 
Aisha Masood
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Stephen Maxted Ansell
Honoraria - Research to Practice; WebMD
Research Funding - Affimed Therapeutics (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); Merck (Inst); Seagen (Inst); Trillium Therapeutics (Inst)